Only 6 left, order soon!
This dual-peptide formulation combines CJC-1295 (No DAC) with Ipamorelin, a selective ghrelin receptor agonist. It is utilized in research exploring synergistic effects on growth hormone release, pituitary signaling, and receptor-specific activation.
CJC-1295 [no DAC] 5mg + IPA 5mg= 10mg total
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.
Laboratory research purposes only and are not intended for human consumption.
Handling and safety information for this product. Click to view the full document.
Open Safety Data Sheet (PDF) in a new tab